41
Growth Score
pts
Heat Score
29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
131384
Revolutionizing treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein
- James Lovgren: Chief Executive Officer & Co-Founder
About the Company
Aspiro Therapeutics is on a mission to revolutionize treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein vital for healthy breathing. We are focused on developing advanced, disease-modifying therapies that target the underlying mechanisms of conditions like asthma and COPD, going beyond symptom
relief to alter the natural course of these diseases.
By harnessing the protective properties of CC16, we aim to restore lung function and prevent disease progression, offering patients safer and more effective treatment options. Through innovation and a commitment to improving respiratory care, we strive to make a lasting impact on the lives of those affected by obstructive lung diseases.
Hispanic / Latine Founded
Hispanic / Latine Led
Women Founded
